Some teens under 18 could soon get a Pfizer COVID-19 booster shot: shot

Keidy Ventura, 17, receives his first dose of Pfizer COVID-19 vaccine in West New York, NJ Pfizer has asked federal authorities to extend booster shot eligibility to 16- and 17-year-olds.

Seth Wenig / AP


hide caption

change caption

Seth Wenig / AP


Keidy Ventura, 17, receives his first dose of Pfizer COVID-19 vaccine in West New York, NJ Pfizer has asked federal authorities to extend booster shot eligibility to 16- and 17-year-olds.

Seth Wenig / AP

For the first time, people under the age of 18 may soon be eligible for a COVID-19 booster shot in the United States

On Tuesday, Pfizer CEO and Chairman Albert Bourla said the vaccine maker had submitted its request to the U.S. Food and Drug Administration to extend the emergency use permit for a booster dose of the Pfizer-BioNTech COVID-19 vaccine to 16- and 17-year-olds.

Bourla made message on Twitter, saying that “it is our hope to provide strong protection for as many people as possible, especially in the light of the new variant” – a reference to omicron, which has not yet been discovered in the US

Currently, only people 18 years of age and older are eligible for a COVID-19 booster shot in the United States, and it must be at least six months after receiving a second dose of either the Pfizer or Moderna vaccines. Adults 18 years and older who received the Johnson & Johnson vaccine can receive a booster after two months.

In October, Pfizer and BioNTech announced the results of a randomized study of 10,000 people 16 years and older who showed a booster dose “restored vaccine protection against COVID-19 to the high levels achieved after the second dose,” according to a press release from the companies.

Pfizer’s efforts to extend the booster eligibility to some adults under the age of 18 come as top federal health officials are urging all Americans who qualify to get a booster shot.

Give a Comment